Ethanolamine kinase: Difference between revisions
CSV import |
CSV import |
||
| (One intermediate revision by the same user not shown) | |||
| Line 26: | Line 26: | ||
[[Category:Biochemistry]] | [[Category:Biochemistry]] | ||
{{enzyme-stub}} | {{enzyme-stub}} | ||
{{No image}} | |||
__NOINDEX__ | |||
Latest revision as of 11:14, 17 March 2025
Ethanolamine kinase (EK) is an enzyme that catalyzes the phosphorylation of ethanolamine, a primary amine and a primary alcohol. This reaction is the first step in the CDP-ethanolamine pathway, which is the primary method for the synthesis of phosphatidylethanolamine in mammalian cells.
Function[edit]
Ethanolamine kinase catalyzes the ATP-dependent phosphorylation of ethanolamine, producing phosphoethanolamine and ADP. This is the first step in the CDP-ethanolamine pathway, which ultimately leads to the production of phosphatidylethanolamine. Phosphatidylethanolamine is a major component of the inner leaflet of the lipid bilayer in mammalian cells and is involved in many cellular processes, including protein folding and membrane fusion.
Structure[edit]
The structure of ethanolamine kinase is not fully understood. However, it is known to be a monomer and is believed to have a two-domain structure. The larger domain is thought to bind ATP and ethanolamine, while the smaller domain is believed to be involved in the transfer of the phosphate group.
Clinical significance[edit]
Alterations in the activity of ethanolamine kinase have been implicated in several diseases. For example, increased activity of this enzyme has been observed in cancer cells, suggesting that it may play a role in tumor growth and progression. Additionally, mutations in the gene encoding ethanolamine kinase have been associated with neurological disorders.
See also[edit]
References[edit]
